

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Although both IWR-1 and XAV939 act as reversible Wnt pathway inhibitors and exhibit similar pharmacological effects both in vitro and in vivo, IWR-1 exerts its effect via interaction with Axin, while XAV939 binds TNKS directly. |
| Concentration | Treated Time | Description | References | |
| iPSC-AETII cells | 100 mM | 7 days | IWR-1 induced the differentiation of iPSC-AETII cells to the AETI cell phenotype, significantly increasing the expression of AETI markers AQ5, T1α, and caveolin-1. | J Clin Invest. 2013 Nov;123(11):4950-62. |
| HUVECs | 5 μM | 2 h | Inhibited Wnt/β-catenin signaling, reduced β-catenin nuclear translocation, thereby counteracting aFGF-mediated endothelial protection. | Redox Biol. 2021 Feb;39:101811. |
| 3T3-L1 cells | 25 μM | Reverse the inhibitory effects of RAL on lipid droplets and adipogenic markers | J Biomed Sci. 2019 Aug 31;26(1):62. | |
| CD44+CD133+ Caco-2 cells | 4.0-64 µM | 6 days | To evaluate the anti-proliferative effects of IWR-1 on CD44+CD133+ Caco-2 cells. The results showed that IWR-1 significantly inhibited the proliferation and colony formation of CD44+CD133+ Caco-2 cells. | Int J Biol Sci. 2021 Apr 12;17(7):1644-1659. |
| mouse primary hepatic cells | 10 μM | 3 h | To investigate the effect of IWR-1 on ethanol-induced lipid accumulation in hepatic cells, results showed that IWR-1 reversed the inhibitory effect of parkin deficiency on lipid accumulation. | Cell Commun Signal. 2019 Aug 22;17(1):104. |
| human hepatic cancer cell line HepG2 | 10 μM | 3 h | To investigate the effect of IWR-1 on β-catenin signaling in HepG2 cells, results showed that IWR-1 inhibited β-catenin ubiquitination. | Cell Commun Signal. 2019 Aug 22;17(1):104. |
| Neural Stem/Progenitor Cells (NSPCs) | 1µM or 10µM | 7 days | IWR-1 significantly inhibited the promoting effect of MIF on NSPC differentiation to neuron lineage | Int J Biol Sci. 2013 Nov 28;9(10):1108-20. |
| Neural Stem/Progenitor Cells (NSPCs) | 10µM | 4 days | IWR-1 significantly inhibited the proliferative effect of MIF on NSPCs | Int J Biol Sci. 2013 Nov 28;9(10):1108-20. |
| Porcine embryonic stem cells | 1.5 µM | 10 days | To evaluate the role of IWR-1 in establishing porcine embryonic stem cells, results showed that IWR-1 helps maintain self-renewal and proliferation capacity of stem cells. | Stem Cell Res Ther. 2024 Aug 7;15(1):245. |
| rat primary hepatocytes | 10 μM | 0.5 h | blocked the effect of coronarin A on β-catenin phosphorylation and inhibited gluconeogenesis | Acta Pharmacol Sin. 2023 Mar;44(3):596-609. |
| human lung endothelial cell (HLEC) | 10 µM | 24 h | restored HLEC tight-junction protein expression and inhibited prostate cancer cell transendothelial migration | Br J Cancer. 2018 May;118(11):1464-1475. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Dbb mice | Intraperitoneal injection | 5 mg/kg | Single injection | Inhibited Wnt/β-catenin signaling, attenuated aFGF-mediated endothelial protection, manifested as increased aortic endothelial cell apoptosis and increased mitochondrial ROS generation. | Redox Biol. 2021 Feb;39:101811. |
| Mice | Parkin knockout mice | Intraperitoneal injection | 25 μM/kg | Single injection | To investigate the effect of IWR-1 on ethanol-induced hepatic lipid accumulation, results showed that IWR-1 reversed the inhibitory effect of parkin deficiency on hepatic lipid accumulation. | Cell Commun Signal. 2019 Aug 22;17(1):104. |
| Mice | Breast cancer xenograft model | 5 mg/kg | Every other day for 2 weeks | The combination of IWR-1 with paclitaxel significantly suppressed breast cancer growth and enhanced the anti-tumor efficacy of paclitaxel. | Cell Death Dis. 2024 Nov 16;15(11):835 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.44mL 0.49mL 0.24mL |
12.21mL 2.44mL 1.22mL |
24.42mL 4.88mL 2.44mL |
|
| CAS号 | 1127442-82-3 |
| 分子式 | C25H19N3O3 |
| 分子量 | 409.44 |
| SMILES Code | O=C(NC1=C2N=CC=CC2=CC=C1)C3=CC=C(N(C([C@]4([H])[C@](C5)([H])C=C[C@]5([H])[C@]64[H])=O)C6=O)C=C3 |
| MDL No. | MFCD18086875 |
| 别名 | IWR-1-endo; endo-IWR 1 |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 50 mg/mL(122.12 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1